Taer, Baby Boy -.
HRN: 21-99-72 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/30/2022
12/07/2022
IV
50mg
Q24
PSNB
Waiting Final Action
Indication: ProphylaxisEmpiricEmpirical De-escalation Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes